4.6 Article

Risk factors for poor prognosis in children with refractory purulent meningitis and the discharge criteria

期刊

JOURNAL OF INFECTION AND PUBLIC HEALTH
卷 11, 期 2, 页码 238-242

出版社

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.jiph.2017.07.007

关键词

Children; Refractory purulent meningitis; Prognosis; Discharge criteria; Antibiotic course

向作者/读者索取更多资源

This study was undertaken to investigate the relationship between cerebrospinal fluid abnormalities and prognosis in pediatric refractory purulent meningitis. Ninety cases of pediatric refractory purulent meningitis were stratified into good (n =33) or poor (n= 57) prognosis groups according to the Glasgow clinical outcome scores. The symptoms, laboratory results, and prognosis were compared by using univariate and multivariate logistic regression analyses. Univariate analysis showed that poor prognosis was associated with: unequal pupil size in both eyes; positive Babinski sign; CSF-WBC >500 x 10(6)/L, CSF protein concentration >1.0 g/L, CSF glucose content <1.5 mmol/L; initial procalcitonin result >0.1 ng/dL on admission; hemoglobin <90 g/L during hospitalization; abnormal head imaging, and abnormal electroencephalogram. On multivariate analysis only unequal pupil size in both eyes and CSF glucose content <1.5 mmol/L remained significant. The CSF protein concentration was significantly different between groups at discharge. The cutoff value was 0.68 g/L. We recommend that discharged patients meet the following criteria: full antibiotic course and over 1 week of defervesce, disappearance of acute phase symptoms, CSF-WBC <28 x 106/L, CSF glucose >1.75 mmol/L, and protein <0.68 g/L. The patient may be discharged for follow-up if no relapse occurs during 3-5 days of observation after drug withdrawal. (C) 2017 Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据